Last reviewed · How we verify
3% diclofenac in 2.5% hyaluronic acid gel — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
3% diclofenac in 2.5% hyaluronic acid gel (3% diclofenac in 2.5% hyaluronic acid gel) — University Hospital Regensburg.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| 3% diclofenac in 2.5% hyaluronic acid gel TARGET | 3% diclofenac in 2.5% hyaluronic acid gel | University Hospital Regensburg | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- 3% diclofenac in 2.5% hyaluronic acid gel CI watch — RSS
- 3% diclofenac in 2.5% hyaluronic acid gel CI watch — Atom
- 3% diclofenac in 2.5% hyaluronic acid gel CI watch — JSON
- 3% diclofenac in 2.5% hyaluronic acid gel alone — RSS
Cite this brief
Drug Landscape (2026). 3% diclofenac in 2.5% hyaluronic acid gel — Competitive Intelligence Brief. https://druglandscape.com/ci/3-diclofenac-in-2-5-hyaluronic-acid-gel. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab